Banff classification and progress on liver allograft pathology
10.3969/j.issn.1674-7445.2021.05.003
- VernacularTitle:Banff移植肝病理学诊断标准及其进展
- Author:
Hui GUO
1
;
Zhenglu WANG
;
Wenming CONG
;
Zhishui CHEN
Author Information
1. Organ Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, Key Laboratory of Organ Transplantation of National Health Commission of China, Key Laboratory of Organ Transplantation of Chinese Academy of Medical Sciences, Wuhan 430030, China
- Publication Type:Research Article
- Keywords:
Allograft pathology;
Liver transplantation;
Biopsy;
Diagnostic classification of pathology;
Antibody-mediated rejection (AMR);
T cell-mediated rejection (TCMR);
Chronic allograft vasculopathy;
Drug induced liver injury
- From:
Organ Transplantation
2021;12(5):512-
- CountryChina
- Language:Chinese
-
Abstract:
The pathology of liver allograft biopsy is not only essential for the evaluation of liver donor, but also for the diagnosis and differential diagnosis of posttransplantation complications. With the development of liver transplantation in clinical practice, relevant studies of the pathological diagnosis of liver allograft complications have been deepened. Banff classification on liver allograft pathology have been gradually established within the international community. In China, pathological studies related to liver allograft pathology have been steadily carried out, and the pathological diagnostic basis of liver allograft pathology suitable for the clinical practice of liver transplantation in China has been gradually formed. This article reviews the history of Banff liver allograft pathology and major pathological lesions of liver allograft complications, aiming to provide reference for implementing pathological diagnosis of liver allograft pathology in China, assisting clinical diagnosis and targeted treatment of complications after liver transplantation, and further improving the survival of liver allograft and recipients.
